Antifibrinolytic therapy - locally-applied tranexamic acid (TXA) mouthwash/solution (SoF eligibility: TXA or EACA; all included trials used topical TXA) vs placebo or usual care
Thromboembolic events · Percutaneous nephrolithotomy
Topical TXA showed no clear difference in thromboembolic events compared with no TXA (placebo or usual care) (moderate certainty).
1 finding from 1 review
- RD 01 study · 400 participantsModerate